Studies of Risk Factors for Aminoglycoside Nephrotoxicity
- 1 November 1986
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 8 (5) , 308-313
- https://doi.org/10.1016/s0272-6386(86)80103-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosidesThe American Journal of Medicine, 1986
- Lack of evidence for interaction between tobramycin and shock in their effect on renal functionAntimicrobial Agents and Chemotherapy, 1985
- Cefotaxime Compared with Nafcillin Plus Tobramycin for Serious Bacterial InfectionsAnnals of Internal Medicine, 1984
- Risk Factors for Nephrotoxicity in Patients Treated with AminoglycosidesAnnals of Internal Medicine, 1984
- Double-Blind Comparison of the Nephrotoxicity and Auditory Toxicity of Gentamicin and TobramycinNew England Journal of Medicine, 1980
- CEPHALOTHIN PLUS AN AMINOGLYCOSIDE IS MORE NEPHROTOXIC THAN METHICILLIN PLUS AN AMINOGLYCOSIDEThe Lancet, 1978
- Controlled Comparison of Amikacin and GentamicinNew England Journal of Medicine, 1977